Aaron Lewis

@J_Lee_Design @BYUCougars With the exception of ND

@BYUCougars Oh easy: -Miami is 4-0 against ranked teams with decisive dominant victories in all of their wins, and their losses were against 8-4 less than 1 possession games with one being OT, and they have a win over ND

Objectively, how do you defend this: Miami (10–2) – ESPN SOS: 45 – ESPN SOR: 14 – Did not play for a conference championship – Losses: Two 8–4 teams (SMU, Louisville) BYU (11–2) – ESPN SOS: 22 – ESPN SOR: 9 – Played in the Big 12 championship – Losses: No. 4 Texas Tech on the road & in the Big 12 title game Notre Dame (10–2) – ESPN SOS: 44 – ESPN SOR: 13 – Did not play for a conference championship – Losses: Miami (who lost to two 8–4 teams) & No. 7 Texas A&M

@J_Lee_Design @BYUCougars Except, none of the ranked teams Miami beat are currently ranked. The preseason rankings are biased to give certain conferences more “ranked” wins.

@HinrichsZane They aren’t fully loaded up… if they are doing to Gigafactory to Fremont runs, or the tire, or the headliner and carpet… those loads are 3,000 lbs to 35,000 lbs. And even some of the loads from gigafactory are mostly empty.

What a delight it was to host HPB session at SocCal ACS 2023 with Naveen Solomon and see so many friends, past trainees and current LA colleagues @M_P_OLeary @AaronLewisMD @UCIrvineSurgery @COH_SurgOnc #zeljkajutric #sujitkulkarni @uscsurgery @LLUHealth @CedarsSinai

@COH_SurgOnc @CityofHopeSurg @AndrewHieu @laleh_melstrom Let’s do this next year!

@COH_SurgOnc smoked the #Rosebowlhalf marathon today. Friends and colleagues @AndrewHieu, #heatherplayer #AaronLewis, not pictured Matt Hernandez, Kip Melstrom, @laleh_melstrom

A 20y timeline on stage at diagnosis & survival in #PancreaticCancer. Per Cancer Statistics 2003, the five year survival of pancreatic cancer overall was 4%. In 2022 it is 12%. Most of those survival gains have come in localized (17% 👉🏽 44%) & regional (7% 👉🏽 15%) disease.

@rao_pbr COH-Bend is next.

Huge news!

The learning curve often is a major obstacle in adopting new and better technologies. Thank you @gall_tamara for your insight in how to do this as safe as possible. It was interesting hearing about the differences in adoption of the robot between US and UK. @COH_SurgOnc

@SoCalYuman @laleh_melstrom @COH_SurgOnc Looking forward to @laleh_melstrom ‘s leadership of the division. I see great things in our future.

We are so happy to have @laleh_melstrom join our great divisional leadership team. She is talented, accomplished, visionary, and kind. Looking forward to future successes of @COH_SurgOnc.

Honored to have been invited professor to the Grand Rounds for The Dept. of Surgery @cityofhope with @YumanFong @AndreasMKaiser to share our experience with Watch&Wait for rectal cancer @hospitalalemao.

@NovartisScience @Novartis ##w

“It’s cool because it’s so simple.” - @Novartis nuclear medicine researcher Germo Gericke, on targeted radioligand therapy bit.ly/3kQ9o6O